OBJECTIVE: The primary objective of this study was to explore the potential influence of gender on recovery from optic neuritis (ON) by determining whether differences in retinal nerve fiber layer (RNFL) thickness can be detected between men and women 6 months after an ON event. METHODS: In this prospective cohort study, 39 men and 105 women with acute ON underwent repeat visual and optical coherence tomography (OCT) testing. The main outcome measures were change in RNFL measurements for male and female patients 6 months after ON. RESULTS: Men were older (mean age = 39 years) than women (35 years) (p = 0.05) in this study, and more men (62%) than women (41%) had a diagnosis of relapsing-remitting multiple sclerosis (MS) (p = 0.02). Because age and MS subtype were 2 significant covariates, both variables were controlled for in multiple regression analyses. Other covariates controlled for in the multivariate regression included disease duration (years), use of disease-modifying therapy (yes/no), and use of high-dose corticosteroids for acute ON (yes/no). After 6 months, mean RNFL values were lower in men (74 μm) than women (91 μm) (p < 0.001). Men showed more apparent change in RNFL thickness in their ON eyes from baseline to 6 months after ON than women (p = 0.003). CONCLUSIONS: There may be differences in recovery between men and women after ON, which can be difficult to detect with conventional visual testing. Our findings raise interesting questions about the potential influence of gender in MS, which may be explored in future studies.
OBJECTIVE: The primary objective of this study was to explore the potential influence of gender on recovery from optic neuritis (ON) by determining whether differences in retinal nerve fiber layer (RNFL) thickness can be detected between men and women 6 months after an ON event. METHODS: In this prospective cohort study, 39 men and 105 women with acute ON underwent repeat visual and optical coherence tomography (OCT) testing. The main outcome measures were change in RNFL measurements for male and female patients 6 months after ON. RESULTS:Men were older (mean age = 39 years) than women (35 years) (p = 0.05) in this study, and more men (62%) than women (41%) had a diagnosis of relapsing-remitting multiple sclerosis (MS) (p = 0.02). Because age and MS subtype were 2 significant covariates, both variables were controlled for in multiple regression analyses. Other covariates controlled for in the multivariate regression included disease duration (years), use of disease-modifying therapy (yes/no), and use of high-dose corticosteroids for acute ON (yes/no). After 6 months, mean RNFL values were lower in men (74 μm) than women (91 μm) (p < 0.001). Men showed more apparent change in RNFL thickness in their ON eyes from baseline to 6 months after ON than women (p = 0.003). CONCLUSIONS: There may be differences in recovery between men and women after ON, which can be difficult to detect with conventional visual testing. Our findings raise interesting questions about the potential influence of gender in MS, which may be explored in future studies.
Authors: Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary Cutter; Laura J Balcer Journal: Nat Clin Pract Neurol Date: 2008-12
Authors: Zhaleh Khaleeli; Olga Ciccarelli; Francesco Manfredonia; Frederik Barkhof; Bruno Brochet; Mara Cercignani; Vincent Dousset; Massimo Filippi; Xavier Montalban; Chris Polman; Marco Rovaris; Alex Rovira; Jaume Sastre-Garriga; Machteld Vellinga; David Miller; Alan Thompson Journal: Ann Neurol Date: 2008-06 Impact factor: 10.422
Authors: Daniel S Reich; Seth A Smith; Eliza M Gordon-Lipkin; Arzu Ozturk; Brian S Caffo; Laura J Balcer; Peter A Calabresi Journal: Arch Neurol Date: 2009-08
Authors: Micheline C Deschênes; Denise Descovich; Michèle Moreau; Louis Granger; George A Kuchel; Tomi S Mikkola; Gordon H Fick; Sylvain Chemtob; Elvire Vaucher; Mark R Lesk Journal: Invest Ophthalmol Vis Sci Date: 2009-12-17 Impact factor: 4.799
Authors: E A Yeh; B Weinstock-Guttman; N Lincoff; J Reynolds; A Weinstock; N Madurai; N Agarwal; P Buch; M Karpinski; M Ramanathan Journal: Mult Scler Date: 2009-05-22 Impact factor: 6.312
Authors: Carmen Tur; Olivia Goodkin; Daniel R Altmann; Thomas M Jenkins; Katherine Miszkiel; Alessia Mirigliani; Camilla Fini; Claudia A M Gandini Wheeler-Kingshott; Alan J Thompson; Olga Ciccarelli; Ahmed T Toosy Journal: Brain Date: 2016-02-17 Impact factor: 13.501
Authors: R M Dachsel; R Dachsel; S Domke; T Groß; O Schubert; L Kotrini; K Ladegast; J Vogel; T Jordan; S Zawade Journal: Nervenarzt Date: 2015-02 Impact factor: 1.214
Authors: Magí Andorrà; Salut Alba-Arbalat; Anna Camos-Carreras; Iñigo Gabilondo; Elena Fraga-Pumar; Ruben Torres-Torres; Irene Pulido-Valdeolivas; Ana I Tercero-Uribe; Ana M Guerrero-Zamora; Santiago Ortiz-Perez; Irati Zubizarreta; Nuria Sola-Valls; Sara Llufriu; Maria Sepulveda; Eugenia Martinez-Hernandez; Thais Armangue; Yolanda Blanco; Pablo Villoslada; Bernardo Sanchez-Dalmau; Albert Saiz; Elena H Martinez-Lapiscina Journal: JAMA Neurol Date: 2020-02-01 Impact factor: 18.302
Authors: Jennifer S Graves; Frederike Cosima Oertel; Anneke Van der Walt; Sara Collorone; Elias S Sotirchos; Gorm Pihl-Jensen; Philipp Albrecht; E Ann Yeh; Shiv Saidha; Jette Frederiksen; Scott Douglas Newsome; Friedemann Paul Journal: Neurol Neuroimmunol Neuroinflamm Date: 2021-12-26